Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?

International Journal of Immunogenetics

Volumn 38, Issue 5, 2011, Pages 383-387

  Poolpol, K ^a   Gadner, B ^a   Neururer, S ^a   Mellmann, A ^b   Karch, H ^b   Orth, D ^a   Wurzner R ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C7; COMPLEMENT FACTOR H;

ALLOTYPE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION; HEMOLYTIC UREMIC SYNDROME; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL;

COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; ESCHERICHIA COLI INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MUTATION;

ESCHERICHIA COLI;

EID: 80052853553     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2011.01017.x     Document Type: Article

References (37)

1. Atkinson, J.P. & Goodship, T.H. (2007) Complement factor H and the hemolytic uremic syndrome. Journal of Experimental Medicine, 204, 1245.
2. Bossi, F., Rizzi, L., Bulla, R., Debeus, A., Tripodo, C., Picotti, P. et al. (2009) C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. Blood, 113, 3640.
3. Caprioli, J., Bettinaglio, P., Zipfel, P.F., Amadei, B., Daina, E., Gamba, S., Skerka, C., Marziliano, N., Remuzzi, G. & Noris, M. (2001) The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. Journal of the American Society of Nephrology, 12, 297.
4. Caprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G. et al. (2003) Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Human Molecular Genetics, 12, 3385.
5. Day, A.J., Willis, A.C., Ripoche, J. & Sim, R.B. (1988) Sequence polymorphism of human complement factor H. Immunogenetics, 27, 211.
6. DiScipio, R.G. (1992) Formation and structure of the C5b-7 complex of the lytic pathway of complement. Journal of Biological Chemistry, 267, 17087.
7. Dragon-Durey, M.A., Loirat, C., Cloarec, S., Macher, M.A., Blouin, J., Nivet, H., Weiss, L., Fridman, W.H. & Fremeaux-Bacchi, V. (2005) Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. Journal of the American Society of Nephrology, 16, 555.
8. Edwards, A.O., Ritter, R. 3rd, Abel, K.J., Manning, A., Panhuysen, C. & Farrer, L.A. (2005) Complement factor H polymorphism and age-related macular degeneration. Science, 308, 421.
9. Evans, J.R., Fletcher, A.E. & Wormald, R.P. (2004) Age-related macular degeneration causing visual impairment in people 75years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology, 111, 513.
10. Friedman, D.S., O'Colmain, B.J., Munoz, B., Tomany, S.C., McCarty, C., de Jong, P.T., Nemesure, B., Mitchell, P. & Kempen, J. (2004) Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology, 122, 564.
11. Haapasalo, K., Jarva, H., Siljander, T., Tewodros, W., Vuopio-Varkila, J. & Jokiranta, T.S. (2008) Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes. Molecular Microbiology, 70, 583.
12. Hageman, G.S., Anderson, D.H., Johnson, L.V., Hancox, L.S., Taiber, A.J., Hardisty, L.I. et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America, 102, 7227.
13. Haines, J.L., Hauser, M.A., Schmidt, S., Scott, W.K., Olson, L.M., Gallins, P. et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science, 308, 419.
14. Jozsi, M., Strobel, S., Dahse, H.M., Liu, W.S., Hoyer, P.F., Oppermann, M., Skerka, C. & Zipfel, P.F. (2007) Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood, 110, 1516.
15. Karch, H., Tarr, P.I. & Bielaszewska, M. (2005) Enterohaemorrhagic Escherichia coli in human medicine. International Journal of Medical Microbiology, 295, 405.
16. Klein, R.J., Zeiss, C., Chew, E.Y., Tsai, J.Y., Sackler, R.S., Haynes, C. et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science, 308, 385.
17. Lachmann, P.J. (1987) Heberden oration 1986. Complement - friend or foe. British Journal of Rheumatology, 26, 409.
18. Monnens, L., Molenaar, J., Lambert, P.H., Proesmans, W. & van Munster, P. (1980) The complement system in hemolytic-uremic syndrome in childhood. Clinical Nephrology, 13, 168.
19. Orth, D., Grif, K., Khan, A.B., Naim, A., Dierich, M.P. & Würzner, R. (2007) The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagnostic Microbiology and Infectious Disease, 59, 235.
20. Orth, D., Khan, A.B., Naim, A., Grif, K., Brockmeyer, J., Karch, H. et al. (2009) Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. Journal of Immunology, 182, 6394.
21. Perez-Caballero, D., Gonzalez-Rubio, C., Gallardo, M.E., Vera, M., Lopez-Trascasa, M., Rodriguez de Cordoba, S. & Sanchez-Corral, P. (2001) Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. American Journal of Human Genetics, 68, 478.
22. Richards, A., Buddles, M.R., Donne, R.L., Kaplan, B.S., Kirk, E., Venning, M.C., Tielemans, C.L., Goodship, J.A. & Goodship, T.H. (2001) Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. American Journal of Human Genetics, 68, 485.
23. Rodriguez de Cordoba, S. & Goicoechea de Jorge, E. (2008) Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clinical and Experimental Immunology, 151, 1.
24. Saunders, R.E., Abarrategui-Garrido, C., Fremeaux-Bacchi, V., Goicoechea de Jorge, E., Goodship, T.H., Lopez Trascasa, M. et al. (2007) The interactive factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models. Human Mutation, 28, 222.
25. Scheiring, J., Andreoli, S.P. & Zimmerhackl, L.B. (2008) Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatric Nephrology, 23, 1749.
26. Skerka, C., Jozsi, M., Zipfel, P.F., Dragon-Durey, M.A. & Fremeaux-Bacchi, V. (2009) Autoantibodies in haemolytic uraemic syndrome (HUS). Thrombosis and Haemostasis, 101, 227.
27. Speth, C., Würzner, R., Stoiber, H. & Dierich, M.P. (2008) Complement. In: Fundamental Immunology (ed. W.E. Paul), p. 1047. Lippincott-Raven, Philadelphia.
28. Sullivan, M., Erlic, Z., Hoffmann, M.M., Arbeiter, K., Patzer, L., Budde, K. et al. (2010) Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome. Annals of Human Genetics, 74, 17.
29. Thakkinstian, A., Han, P., McEvoy, M., Smith, W., Hoh, J., Magnusson, K., Zhang, K. & Attia, J. (2006) Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration. Human Molecular Genetics, 15, 2784.
30. Thurman, J.M., Marians, R., Emlen, W., Wood, S., Smith, C., Akana, H. et al. (2009) Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clinical Journal of the American Society of Nephrology, 4, 1920.
31. Warwicker, P., Goodship, T.H.J., Donne, R.L., Pirson, Y., Nicholls, A., Ward, R.M., Turpenny, P. & Goodship, J.A. (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney International, 53, 836.
32. Würzner, R. (2000) Modulation of complement membrane attack by local C7 synthesis. Clinical and Experimental Immunology, 121, 8.
33. Würzner, R., Nitze, R. & Götze, O. (1990) C7*9, a new frequent C7 allele detected by an allotype-specific monoclonal antibody. Complement and Inflammation, 7, 290.
34. Würzner, R., Tokunaga, K., Nitze, R., Götze, O. & Lachmann, P.J. (1991) C7*N is a hypomorphic allele of the human complement C7M/N protein polymorphism. Experimental and Clinical Immunogenetics, 8, 177.
35. Würzner, R., Hobart, M.J., Orren, A., Tokunaga, K., Nitze, R., Götze, O. & Lachmann, P.J. (1992) A novel protein polymorphism of human complement C7 detected by a monoclonal antibody. Immunogenetics, 35, 398.
36. Würzner, R., Fernie, B.A., Jones, A.M., Lachmann, P.J. & Hobart, M.J. (1995a) Molecular basis of the complement C7M/N polymorphism. A neutral amino acid substitution outside the epitope of the allospecific monoclonal antibody WU 4-15. Journal of Immunology, 154, 4813.
37. Würzner, R., Sölder, B.M., Prodinger, W.M. & Dierich, M.P. (1995b) Complement C7M/N allotyping in infectious diseases. Experimental and Clinical Immunogenetics, 12, 61.